Christoph Rentsch
Directeur/Bestuurslid bij Targimmune Therapeutics AG
Actieve functies van Christoph Rentsch
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Directeur/Bestuurslid | - | - |
Loopbaan van Christoph Rentsch
Eerdere bekende functies van Christoph Rentsch
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SANTHERA PHARMACEUTICALS HOLDING AG | Financieel Directeur/CFO | 01-07-2015 | 31-12-2019 |
Public Communications Contact | 01-07-2015 | 31-12-2019 | |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Directeur/Bestuurslid | - | - |
Credit Suisse AG
Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Corporate Officer/Principal | - | - |
Alusuisse-Lonza America, Inc. | Financieel Directeur/CFO | - | - |
Alusuisse Group Ltd. | Treasurer | - | - |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - | - |
Caperis Partners AG | Corporate Officer/Principal | 01-01-2003 | - |
SPEXIS AG | Financieel Directeur/CFO | - | - |
Opleiding van Christoph Rentsch
University of Applied Sciences Basel | Undergraduate Degree |
Statistieken
Internationaal
Zwitserland | 10 |
Verenigde Staten | 2 |
Operationeel
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Sectoraal
Health Technology | 5 |
Finance | 3 |
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
SPEXIS AG | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Credit Suisse AG
Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Finance |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Alusuisse Group Ltd. | Distribution Services |
Alusuisse-Lonza America, Inc. | |
Caperis Partners AG | |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
- Beurs
- Insiders
- Christoph Rentsch
- Ervaring